Ultralife Corp. (NASDAQ: ULBI) reported Q3 EPS of $0.07, $0.14 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $43.4 million versus the consensus estimate of $53 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.